GO
Loading...

Spain

More

  • Foreign banks resist losses on Spanish motorway rescue Wednesday, 1 Oct 2014 | 11:00 AM ET

    *Cash-strapped Spain reluctant to take on bulk of loans. MADRID, Oct 1- Foreign banks are dragging out a 2.3 billion euro rescue plan for bankrupt Spanish motorways, seeking better terms to recoup more of the money they lent the nine toll road companies, three sources said.

  • European shares edge lower after manufacturing data Wednesday, 1 Oct 2014 | 6:59 AM ET

    *Nexans, Sainsbury drop after warning on sales outlook. LONDON/ PARIS, Oct 1- European shares edged lower on Wednesday, following mixed data on manufacturing and sales warnings from J Sainsbury and Nexans that fuelled worries over European corporate results.

  • *France postpones deficit reduction by a further two years. PARIS, Oct 1- France laid down the gauntlet to EU partners on Wednesday with a 2015 budget setting out how it would bring its borrowing back to within EU limits two years later than promised, a retreat it blamed on a fragile economy.

  • Europe shares dip after mixed manufacturing data Wednesday, 1 Oct 2014 | 4:35 AM ET

    *Nexans, Sainsbury drop after warning on sales outlook. PARIS, Oct 1- European shares dipped on Wednesday following mixed manufacturing data and as sales warnings from J Sainsbury and Nexans fueled worries over the outlook for European corporate results.

  • *Mood swing from austerity seen helping France's case. PARIS, Sept 30- From Athens to Madrid and Dublin to Rome, France can count on a sympathetic hearing in several European capitals in its campaign for leniency over the latest broken promise to bring its public finances into shape.

  • MADRID, Sept 30- A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects-- but their high cost is a growing concern. Price-- just as much as safety and efficacy-- has proved a hot topic for nearly 20,000 oncology experts at the European Society for Medical Oncology annual congress in Madrid.

  • MADRID, Sept 29- Spain's Constitutional Court suspended on Monday an independence referendum called by Catalonia for November, although political forces in the wealthy north-east region forged ahead with a political campaign ahead of their planned vote.

  • LONDON, Sept 29- Greek government bond yields rose to their highest in almost two months on Monday as Athens' plans for an early exit from a bailout programme raised concerns about future financing and debt relief.

  • TORONTO, Sept 29- Even as BlackBerry pivots to focus more on software and services, the company that gained fame for its smartphones is not giving up on its handset business, two senior executives said.

  • Bubble bubble, toil and global troubles hit stocks Monday, 29 Sep 2014 | 9:57 AM ET
    Riot police use pepper spray as they clash with protesters, as tens of thousands of protesters block the main street to the financial Central district outside the government headquarters in Hong Kong September 28, 2014.

    Brazil, Hong Kong, Spain —take your pick. International uncertainty abounds, and it's spilling over into U.S. markets.

  • By Barbara Lewis and Adrian Croft. BRUSSELS, Sept 29- European Union regulators will provide more details on Tuesday of their reasons for launching in-depth inquiries into tax arrangements reached by Ireland with Apple and by Luxembourg with a Fiat subsidiary.

  • *Roche set to compete with established GSK combination. *Shares in Roche's biotech partner Exelixis jump 20 pct. MADRID, Sept 29- Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline had similarly good results in separate clinical trials, leaving doctors with little to choose between the two skin cancer courses.

  • *Perjeta builds on Roche's strong position in breast cancer. MADRID, Sept 28- A new breast cancer drug from Roche has shown "unprecedented" benefits in extending lives in a clinical trial and experts urged its widespread use for women with an aggressive form of the disease.

  • MADRID, Sept 28- Merck& Co's drug Keytruda, the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, also has potential in stomach cancer, new research shows.

  • *Perjeta builds on Roche's strong position in breast cancer. MADRID, Sept 28- A new breast cancer drug from Roche has shown "unprecedented" survival benefits in a clinical trial, boosting prospects for its widespread use in women with an aggressive form of the disease.

  • MADRID- ROCHE'S PERJETA DRUG ADDS 15.7 MONTHS SURVIVAL BENEFIT IN METASTATIC BREAST CANCER STUDY.

  • MADRID/ SYDNEY, Sept 28- A year after Spain, the sunniest country in Europe, issued notice of a law forcing solar energy-equipped homes and offices to pay a punitive tax, architect Inaki Alonso re-installed a 250 watt solar panel on a beam over his Madrid roof terrace.

  • *AstraZeneca says tolerability profile encouraging. MADRID, Sept 27- Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system show the cocktail is promising, though limited patient numbers mean the data is far from conclusive.

  • Sept 27- Pfizer Inc's Xalkori, which treats lung cancer patients with a specific gene mutation, proved effective in shrinking tumors in those with an even rarer form of the disease, according to data presented at a medical meeting on Saturday.

  • *AstraZeneca says tolerability profile encouraging. MADRID, Sept 27- Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system suggest the cocktail is promising, though limited patient numbers mean the data is far from conclusive.